Danny Zanardo - Anteris Technologies Commercial International
Executive
Mr. Danny Zanardo is Director of Sales of Admedus Ltd, formerly Allied Healthcare Group Ltd. He has over 20 years experience in the Australian healthcare sector via positions with multinational pharmaceutical companies, biopharmaceutical startup, and medical device companies. He has gained formal qualifications via a degree in applied science and has built upon this with post graduate business studies, and is currently working towards completing his MBA. During his career, he has developed networks and an intimate understanding of medical device and pharmaceutical commercial and clinical environments. He has a track record of sales, marketing and clinical teams in commercial projects, with new and existing medical technology, that have resulted in revenue growth. Danny has worked with Rousell Uclaf, Hoffman La Roche, and Actelion. He joined Allied Medical as a Regional Sales Manager in 2004 and became National Sales Manager in 2005.
| Professional Marks | MBA |
| Phone | 61 13 0055 0310 |
| Web | https://www.anteristech.com |
Anteris Technologies Management Efficiency
The company has return on total asset (ROA) of (0.8433) % which means that it has lost $0.8433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5517) %, meaning that it generated substantial loss on money invested by shareholders. Anteris Technologies' management efficiency ratios could be used to measure how well Anteris Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Anteris Technologies has accumulated 4.07 M in total debt with debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from borrowing. Anteris Technologies has a current ratio of 4.22, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Anteris Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Anteris Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Anteris Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Anteris to invest in growth at high rates of return. When we think about Anteris Technologies' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 5 records | EXECUTIVE Age | ||
| Kevin Williamson | Tenon Medical | 40 | |
| Lawrence Lin | Ainos Inc | 55 | |
| Steve Moscaret | Tenon Medical | N/A | |
| MengLin Sung | Ainos Inc | 51 | |
| HsinLiang Lee | Ainos Inc | 54 | |
Management Performance
| Return On Equity | -2.55 | |||
| Return On Asset | -0.84 |
Anteris Technologies Leadership Team
Elected by the shareholders, the Anteris Technologies' board of directors comprises two types of representatives: Anteris Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anteris. The board's role is to monitor Anteris Technologies' management team and ensure that shareholders' interests are well served. Anteris Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anteris Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| AC FAA, Exec | ||
| Wayne Paterson, Non-Executive Independent Director | ||
| Matthew McDonnell, Chief Officer | ||
| David Denis, Chief Officer | ||
| Stephen Denaro, Independent Sec | ||
| Chris Olig, Bus Director | ||
| Danny Zanardo, Commercial International | ||
| MPH MD, Chief Board |
Anteris Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Anteris Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.55 | |||
| Return On Asset | -0.84 | |||
| Operating Margin | (5.05) % | |||
| Current Valuation | 196.49 M | |||
| Shares Outstanding | 13.9 M | |||
| Shares Owned By Insiders | 13.27 % | |||
| Shares Owned By Institutions | 28.34 % | |||
| Price To Earning | (3.20) X | |||
| Price To Book | 10.09 X | |||
| Price To Sales | 30.51 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Anteris Pink Sheet
If you are still planning to invest in Anteris Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anteris Technologies' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |